US20140341786A1 - Cold plasma setrilization device - Google Patents
Cold plasma setrilization device Download PDFInfo
- Publication number
- US20140341786A1 US20140341786A1 US14/455,910 US201414455910A US2014341786A1 US 20140341786 A1 US20140341786 A1 US 20140341786A1 US 201414455910 A US201414455910 A US 201414455910A US 2014341786 A1 US2014341786 A1 US 2014341786A1
- Authority
- US
- United States
- Prior art keywords
- sterilization device
- resistor
- applicator
- gas
- plasma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 230000005495 cold plasma Effects 0.000 title claims abstract description 18
- 238000004659 sterilization and disinfection Methods 0.000 claims abstract description 24
- 230000001954 sterilising effect Effects 0.000 claims abstract description 23
- 238000000034 method Methods 0.000 claims abstract description 12
- 239000007789 gas Substances 0.000 claims description 45
- 239000011261 inert gas Substances 0.000 claims description 6
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 claims description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 4
- 230000005684 electric field Effects 0.000 claims description 3
- 239000002923 metal particle Substances 0.000 claims description 3
- 229920000049 Carbon (fiber) Polymers 0.000 claims description 2
- 229910052786 argon Inorganic materials 0.000 claims description 2
- 239000004917 carbon fiber Substances 0.000 claims description 2
- 229910021393 carbon nanotube Inorganic materials 0.000 claims description 2
- 239000002041 carbon nanotube Substances 0.000 claims description 2
- 229920001940 conductive polymer Polymers 0.000 claims description 2
- 229910002804 graphite Inorganic materials 0.000 claims description 2
- 239000010439 graphite Substances 0.000 claims description 2
- 239000001307 helium Substances 0.000 claims description 2
- 229910052734 helium Inorganic materials 0.000 claims description 2
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 claims description 2
- 229910044991 metal oxide Inorganic materials 0.000 claims description 2
- 150000004706 metal oxides Chemical class 0.000 claims description 2
- 239000011810 insulating material Substances 0.000 claims 1
- 238000005202 decontamination Methods 0.000 abstract description 16
- 230000003588 decontaminative effect Effects 0.000 abstract description 16
- 210000002381 plasma Anatomy 0.000 description 51
- 239000004593 Epoxy Substances 0.000 description 9
- 239000000758 substrate Substances 0.000 description 8
- 239000004020 conductor Substances 0.000 description 6
- 238000007781 pre-processing Methods 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 230000000694 effects Effects 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 4
- 239000012159 carrier gas Substances 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 239000001301 oxygen Substances 0.000 description 4
- 229910052760 oxygen Inorganic materials 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 238000003860 storage Methods 0.000 description 4
- 230000009471 action Effects 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- 150000002500 ions Chemical class 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000000356 contaminant Substances 0.000 description 2
- 238000011109 contamination Methods 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000009792 diffusion process Methods 0.000 description 2
- 238000010304 firing Methods 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 241000233866 Fungi Species 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 1
- 238000002679 ablation Methods 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 239000003124 biologic agent Substances 0.000 description 1
- -1 biologicals Substances 0.000 description 1
- 229960000074 biopharmaceutical Drugs 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 230000002939 deleterious effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 239000000383 hazardous chemical Substances 0.000 description 1
- 239000002920 hazardous waste Substances 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 238000012994 industrial processing Methods 0.000 description 1
- 239000002440 industrial waste Substances 0.000 description 1
- 238000010849 ion bombardment Methods 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 239000003973 paint Substances 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 239000003247 radioactive fallout Substances 0.000 description 1
- 239000003642 reactive oxygen metabolite Substances 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 239000000779 smoke Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000009849 vacuum degassing Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Images
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J19/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J19/08—Processes employing the direct application of electric or wave energy, or particle radiation; Apparatus therefor
- B01J19/087—Processes employing the direct application of electric or wave energy, or particle radiation; Apparatus therefor employing electric or magnetic energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
- A61L2/14—Plasma, i.e. ionised gases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
- A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L9/00—Disinfection, sterilisation or deodorisation of air
- A61L9/16—Disinfection, sterilisation or deodorisation of air using physical phenomena
- A61L9/22—Ionisation
-
- H—ELECTRICITY
- H05—ELECTRIC TECHNIQUES NOT OTHERWISE PROVIDED FOR
- H05H—PLASMA TECHNIQUE; PRODUCTION OF ACCELERATED ELECTRICALLY-CHARGED PARTICLES OR OF NEUTRONS; PRODUCTION OR ACCELERATION OF NEUTRAL MOLECULAR OR ATOMIC BEAMS
- H05H1/00—Generating plasma; Handling plasma
- H05H1/24—Generating plasma
- H05H1/46—Generating plasma using applied electromagnetic fields, e.g. high frequency or microwave energy
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/08—Processes employing the direct application of electric or wave energy, or particle radiation; Apparatus therefor
- B01J2219/0894—Processes carried out in the presence of a plasma
- B01J2219/0896—Cold plasma
-
- H—ELECTRICITY
- H05—ELECTRIC TECHNIQUES NOT OTHERWISE PROVIDED FOR
- H05H—PLASMA TECHNIQUE; PRODUCTION OF ACCELERATED ELECTRICALLY-CHARGED PARTICLES OR OF NEUTRONS; PRODUCTION OR ACCELERATION OF NEUTRAL MOLECULAR OR ATOMIC BEAMS
- H05H1/00—Generating plasma; Handling plasma
- H05H1/24—Generating plasma
- H05H1/46—Generating plasma using applied electromagnetic fields, e.g. high frequency or microwave energy
- H05H1/461—Microwave discharges
- H05H1/463—Microwave discharges using antennas or applicators
-
- H—ELECTRICITY
- H05—ELECTRIC TECHNIQUES NOT OTHERWISE PROVIDED FOR
- H05H—PLASMA TECHNIQUE; PRODUCTION OF ACCELERATED ELECTRICALLY-CHARGED PARTICLES OR OF NEUTRONS; PRODUCTION OR ACCELERATION OF NEUTRAL MOLECULAR OR ATOMIC BEAMS
- H05H1/00—Generating plasma; Handling plasma
- H05H1/24—Generating plasma
- H05H1/46—Generating plasma using applied electromagnetic fields, e.g. high frequency or microwave energy
- H05H1/4645—Radiofrequency discharges
- H05H1/466—Radiofrequency discharges using capacitive coupling means, e.g. electrodes
-
- H—ELECTRICITY
- H05—ELECTRIC TECHNIQUES NOT OTHERWISE PROVIDED FOR
- H05H—PLASMA TECHNIQUE; PRODUCTION OF ACCELERATED ELECTRICALLY-CHARGED PARTICLES OR OF NEUTRONS; PRODUCTION OR ACCELERATION OF NEUTRAL MOLECULAR OR ATOMIC BEAMS
- H05H2245/00—Applications of plasma devices
- H05H2245/30—Medical applications
- H05H2245/36—Sterilisation of objects, liquids, volumes or surfaces
Definitions
- Atmospheric discharge cold plasma technology has been employed by the medical community for several years.
- high power uses include tissue ablation, suture sealing and sterilization of a tissue area.
- Low power uses may include dermatologic, hemostasis and other health-field related applications.
- the term “cold plasma” is used to indicate that only a small fraction of the inert carrier gas is ionized, although this fraction can be adjusted to suit the particular use or application.
- the ionized portion of the carrier gas can range between approximately 10 ⁇ 6 (a very weak plasma beam) to approximately 10 ⁇ 3 (a strong beam).
- a plasma can be formed where a gas is exposed to a specific amount of energy, and that energy exposure separates the gas component molecules into a collection of ions, electrons, charge-neutral gas molecules, and other species in varying degrees of excitation. Effectiveness has been demonstrated in rapid sterilization, decontamination and industrial processing. Unlike semiconductor industry applications, the cold plasma technology does not require a vacuum chamber. The plasma discharge is conducted in the open air.
- the mean electron energy (or temperature) of a cold plasma is considerably higher than that of the bulk-gas molecules. Energy is primarily added to the electrons rather than the ions and background gas molecules, and the electrons can attain energies of approximately 10 ⁇ 1 eV or higher, while background gas remains at ambient temperature. A significant energy savings can be realized since electrons are preferentially excited and larger ions are left in a lower energy state in a cold plasma.
- a plasma may also be formed when a modulated electric field is applied to a pair of electrodes and exposed to the gas.
- the plasma formation can cause oxygen molecules of the air passing near the electrodes to break down into component molecules, including reactive oxygen species (“ROS”).
- ROS reactive oxygen species
- Organic substrates, such as bacteria, viruses, microbes and mold spores can be exposed to ROS, and then destroyed or rendered harmless rapidly. The same reaction can convert much or all of the ROS back into oxygen.
- Cold plasmas can provide rapid decontamination of clothing, equipment or gear, and sterilization of medical equipment or food.
- present methods of decontamination and sterilization may require long periods of time, even hours or days and generate damaging heat in the process; a cold plasma of the present disclosure can often sanitize an area or object very briefly, in seconds or minutes.
- This disclosure relates to a decontamination Device having, at least, a gas source, where the gas is typically an inert gas, a gas manifold, at least one resistor network, which may be formed of various types of resistors, and a power source.
- the Device forms a plasma that may be employed to decontaminate large areas rapidly and efficiently in a variety applications.
- FIG. 1 is a cross-sectional view of the general formation of the bulk distributed resistor.
- the disclosed atmospheric discharge cold plasma device (the “Device”) is a large-area mechanism to provide decontamination, sterilization and general “clean-up” with, inter alia, nuclear fallout or waste, biologicals, chemicals, and industrial waste.
- the Device may be employed in any setting, including in urban outdoor areas, in medical facilities, military facilities, airplane hangers, storage facilities, inside tanks and other holding facilities, and the like.
- the Device may be operated remotely, preset for operation, or manually operated. It may also be disposable or reusable.
- the Device provides great advantages over the cold plasma prior art, which is generally directed to medical uses, because very large areas may be decontaminated or sterilized rapidly, and no prior preparation of the area is required in any way. Electrosurgical uses of plasma are disclosed in, inter alia, U.S. Application 2004/0116918, which is incorporated herein in its entirety.
- the Device's plasma beam is emitted via the applicator portion of the Device and can have multiple modes of action to achieve the desired effect. These modes include ion bombardment, electron bombardment, thermal effects, ultra-violet emissions, and the local generation of ozone. Via any of these modes, and combinations thereof, the flowing inert carrier gas can help carry away debris, and expose a clean, fresh surface.
- the ratio of electrical energy input to carrier gas flow rate can be adjusted over a wide range, to allow the overall effect to be varied over a wide range.
- the device has a scalable approach to producing a large area plasma applicator, which can range from approximately one millimeter diameter pin-point beam to a much larger area beam array, which may be approximately a square meter area or more.
- a large plasma beam area can be employed as a plasma scrub brush for use in a variety of situations for decontamination and/or sterilization.
- Devices can be built in a manner that allows flexibility and can adjust to contoured surfaces. Such flexibility may be employed in an even wider number of circumstances including holding tanks, reactors, and the like.
- One of the primary benefits of the Device, and atmospheric discharge cold plasma technology, is the combined impact of multiple modes of action that provide an antimicrobial action against a wide spectrum of organisms and spores, including bacteria, viruses, microbes, fungi, and the like. This same effect would allow for decontamination of a wide spectrum of biological agents typically deployed in biological weapons of mass destruction, and yet cause little or no collateral damage to the substrate during decontamination.
- the Device can be formed to permit safe and relatively rapid decontamination of large affected areas as compared to more typical or traditional clean-up methods.
- the Device does not use hazardous chemicals or generate hazardous waste streams, unlike previously known devices and clean-up methods.
- the Device may also be employed against chemicals using the same modes of plasma action by breaking down chemical bonds of chemical weapons agents, by reducing chemicals to simple compounds such as water, carbon dioxide, and the like.
- the Device as a plasma scrub bush would be particularly effective to decontaminate porous substrates and surfaces which are highly problematic in such situations.
- the Device can decontaminate the porous surfaces of these substrates because the individual plasma beams can travel to the substrate surface despite uneven surface levels. Again, the Device has little or no deleterious effect(s) on the substrate itself.
- the Device may also be used to remove, isolate or destroy radioisotope compounds, particularly those associated with weapons.
- radioisotope compounds particularly those associated with weapons.
- the goal of removing and isolating radioisotopes from the affected area can be accomplished by applying the cold plasma technology in a practical large area applicator such as the plasma scrub brush.
- the Device frees the isotopes from the contaminated surface for subsequent removal. For example, a radioactive compound can be broken down into its constituent components, including water. The isotope can then be removed from the substrate with the Device and disposed of readily with the other components.
- Plasma “preprocessing” is employed in various industries to remove contaminants from surfaces. At higher powers, the plasma preprocessing can also roughen surfaces on a micro scale and in the case of polymers, create dangling bonds. These processes are used to enhance subsequent surface procedures such as coatings, adhesion and the like but typically require the use of a vacuum chamber in the prior art to apply a plasma at sub-atmospheric pressures. This is particularly problematic with large or oddly shaped/non symmetrical objects or surfaces.
- the Device can be employed to preprocess or treat objects of any arbitrary size or shape in a safe environment. Preprocessing with the Device can also permit rapid assessment of effectiveness of any preprocessing procedure, and allow subsequent processes to proceed as may be necessary without breaking a vacuum seal, if a vacuum used.
- preprocessing of surfaces for hip or knee implant replacements can improve bone adhesion(s).
- Preprocessing can also, for example, promote adhesion of non-stick materials to other substrates or assist adhesion of markings to surfaces where the necessary markings would otherwise wipe off.
- the Device may be formed in any convenient physical size depending on an intended use. Medical use Devices may be small hand-held tools or larger wall-mounted tools on swing arms or tracks to be positioned as necessary during a medical procedure. Medical Devices may be formed as single-use articles or multiple use with re-sterilization. Larger Devices may be formed in the sizes of household or industrial vacuums, or in any convenient size that may fulfill a particular or general use need.
- the Device may use any convenient power source, which may generally be determined by the intended use at the time of manufacture. For example, a Device intended for reuse or multiple uses that might be employed, for example, in a hospital setting may run via an electrical cord. Alternatively, a Device that is manufactured for a one time use may be run on a battery, or, perhaps, a solar charge battery for larger areas.
- the Device 100 can include a gas storage tank, or holding location, and typically the gas would be a noble or inert gas, such as helium or argon.
- the gas storage tank can be operatively connected to a conduit 102 to provide a source of gas to be fed into the Device.
- the conduit 102 leads to the electrodes 104 .
- the electrodes 104 when activated, at least partially ionize the gas to create the plasma stream or streams 106 .
- the number of plasma streams 106 will be dependent on the size of the Device 100 itself, and the size of the Device applicator which may be formed as large as approximately a square meter or more.
- Power input 108 into the Device 100 can run through a power distribution electrode 110 into a bulk distributed resistor 112 , as described below, or individual ballast resistors depending on the size of the applicator.
- a plasma beam 106 can be formed by passing the gas over a sharp conductive point, generally of an electrical flow wire, which is held at a relatively high voltage, generally greater than 1 KV, and at a relatively high frequency, generally in the range of approximately 10 KHz to approximately 10 GHz.
- a sintered metal component may be employed to provide a sharp conductor necessary to create the strong electric field gradient which helps pull electrons off the inert gas molecules and ionize them.
- the metal particle edges of a sintered metal component can act as sharp conductive points.
- Ballast resistors may be employed to prevent plasma beams from simultaneously functioning or firing, as depicted in FIG. 1 .
- the plasma beam may exhibit negative resistance and can prevent additional beams from functioning or firing.
- the associated resistance values can range from approximately 1 K ⁇ to approximately 10 M ⁇ .
- Individual resistors at least one resistor or a plurality of resistors, may be used in cases where the number of resistors necessary or required to function with the area of a particular applicator would not become unwieldy.
- individual resistors can be problematic where large numbers of resistors may be involved as in large area applicators. Rather than employ several hundreds or thousands of resistors for use with one applicator, a combined bulk distributed resistor can be used as a resistor network.
- the bulk distributed resistor can be formed of a slow cure epoxy that can be blended with at least one conductive component to produce a desired level of equivalent resistance.
- the bulk distributed resistor may be formed of other materials, such as, for example, room-temperature vulcanizing (“RTV”) rubber, silicones, polymers, and other materials and combinations that can combine with conductive components and that can be hardened or harden sufficiently for use.
- RTV room-temperature vulcanizing
- the conductive component can be formed of carbon nanotubes, carbon fibers, graphite powers, conductive metal particles, conductive metal oxides, conductive polymers, or a combination thereof.
- the conductive component may form a percentage of the resistor material in the range of approximately 0.1% or less to approximately 80% or some what higher.
- the amount of conductive materials formed in the resistor may be in the range of approximately 25% to approximately 60%. In yet another embodiment, the amount of conductive materials formed in the resistor may be in the range of approximately 35% to approximately 45%.
- the epoxy is poured into an appropriate mold, depending, inter alia, on the desired size, shape and flexibility for a particular form of the Device. The epoxy may then be subjected to vacuum degassing to remove most, if not all, of any air bubbles that may have formed during the molding process.
- the bulk distributed resistor can be formed in a pin grid array.
- a pin grid array can be inserted into the epoxy to an approximate depth of not more than half the depth of the mold and rigidly held in the desired position until the epoxy has cured. Once the epoxy has cured, the hardened epoxy is removed from the mold and the pin array, leaving individual channels for emitting a plasma beam through the applicator.
- the equivalent resistance of the bulk distributed resistor can have values of approximately 1 K ⁇ to approximately 10 M ⁇ between any pin and a common distribution electrode.
- a common distribution electrode 110 can be attached to the epoxy surface near the power input source 108 .
- the electrode 110 may be formed of conductive paints, an additional epoxy layer of higher conductivity, a metal plate or some combination thereof.
- a plurality of channels may be formed through the bulk resistor to allow electrical flow, or other type of power, to contact the gas as the gas flows through a gas manifold 103 having an input 102 that is connected, directly or indirectly, to the gas storage tank. The electrical flow can ionize the gas as the power passes into the gas manifold 103 and forms a plasma stream 106 at the point of the electrical flow wire 104 .
- the plasma stream 106 may then flow through an emitter or output channel 114 that is operatively formed on the gas manifold 103 approximately opposite the bulk resistor 112 .
- a myriad number of plasma beam emitters 114 may be formed.
- the emitters 114 can transect the Device applicator to allow the plasma beams 106 to contact a surface outside the Device 100 . Decontamination of a surface in contact with the Device's plasma beam 106 then occurs rapidly, with seconds or minutes. Decontamination time frames may vary based on a number of factors, including the type of surface, the type of contamination, additional biological and/or chemical compounds present, and temperature.
- an intermediate electronegative gas conduit may optionally be disposed in a coaxial relationship relative to the gas conduit.
- a second gas conduit can be used to supply an electronegative gas, or air such as oxygen and nitrogen to maintain the plasma stream.
- an outer aspiration conduit may also be coupled to a negative pressure source, such as a vacuum, that can be disposed in surrounding coaxial relationship, and also recessed, relative to the electronegative gas conduit.
- An aspiration conduit can optionally be used to remove fluid and solid debris from the decontamination area, if desired.
- oxygen and nitrogen in the atmosphere surrounding a plasma beam can tend to confine the plasma discharge to an elongated narrow beam.
- the gas flow from the plasma stream displaces any air remaining within the cavity.
- the intermediate electronegative gas conduit can be employed. This intermediate electronegative gas conduit extends beyond the inner gas conduit in order to maintain a laminar coaxial flow. Gas and air flow rates are generally equal. However, air flow rates in excess of the gas flow rate can be used to enhance flow-assisted removal of smoke and debris generated during use of the Device, if desired. Excessive flow rates of either the gas or air can induce turbulence in the plasma stream and distort the discharge jet shape.
- Cross-boundary diffusion from the plasma stream into the surrounding air and air diffusion into the plasma stream can limit the effective length of the plasma stream.
- Inert gas can be substituted in place of additional gas flow in the intermediate electronegative gas conduit, which can significantly extend the plasma stream, if desired for a specific environment.
- a reduced concentration gradient of the gas can occur from an ionized jet diffusing into non-ionized gas and vice versa. This reduced concentration gradient can result in an overall plasma stream that can be approximately two and two and one-half times as long as plasma streams without a coaxial gas flow.
- the disclosed Device addresses the pressing problem of decontaminating an area without further risk to life or exposure.
- a contaminated area can be secured and sterilized or decontaminated without direct human contact in a large number of settings that would prove unsafe or even dangerous for humans in short term of prolonged contact with the contaminants.
- the Device is also ideal for decontamination of interior surfaces and areas, such as holding tanks, because the Device can be formed using a flexible applicator to adapt to specific environments and uses, and avoid human exposure to high contamination levels enclosed within a tank.
- the disclosed cold plasma Device has many uses in different fields and applications, such as, inter alia, control of air flow over a variety of airfoil surfaces, including missiles, airplane wings, airplane rudders and the like.
- Use of the Devise for plasma actuation may provide rapid control of the air flow for enhanced control of the direction and maneuverability.
- Such uses include those disclosed in U.S. Pat. Nos. 7,070,144, and 7,275,013; and U.S. Patent Applications 2006/0005545, and 2007/0089795, each of which is incorporated herein in its entirety.
- US Patent Application 2007/0089795 discloses a fluid actuator, or a plurality of actuators, having two conductors, or a plurality of conductors, on a dielectric.
- the application of voltage to a conductor may form a plasma flow which can be modified and controlled in a desired direction.
- microwave absorbing characteristics of discharge plasmas which may form a “plasma shield” at higher intensities.
- a plasma shield would prove an effective defense against beamed-microwave directed energy weapons.
- the plasma's degree of ionization will increase, to become more effective and self-reinforcing.
- Such disclosures include U.S. Pat. Nos. 4,897,285 and 6,492,951, which are incorporated herein in their entirety.
- the Device and its bulk resistor system, may be employed with any of the incorporated disclosures, above.
- the Device may provide highly efficient applications of plasma having greater plasma output over a greater surface area, according to the desired use.
Landscapes
- Physics & Mathematics (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Plasma & Fusion (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Electromagnetism (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Toxicology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Apparatus For Disinfection Or Sterilisation (AREA)
Abstract
Description
- The present application is a continuation application of U.S. application Ser. No. 12/012,446, filed Feb. 2, 2008, the contents of which are hereby incorporated by reference.
- A large-area cold plasma decontamination device for decontamination of nuclear, biological, medical and chemical incidents in military, industrial and civilian situations.
- Atmospheric discharge cold plasma technology has been employed by the medical community for several years. Examples of high power uses include tissue ablation, suture sealing and sterilization of a tissue area. Low power uses may include dermatologic, hemostasis and other health-field related applications.
- The term “cold plasma” is used to indicate that only a small fraction of the inert carrier gas is ionized, although this fraction can be adjusted to suit the particular use or application. Typically, the ionized portion of the carrier gas can range between approximately 10−6 (a very weak plasma beam) to approximately 10−3 (a strong beam). A plasma can be formed where a gas is exposed to a specific amount of energy, and that energy exposure separates the gas component molecules into a collection of ions, electrons, charge-neutral gas molecules, and other species in varying degrees of excitation. Effectiveness has been demonstrated in rapid sterilization, decontamination and industrial processing. Unlike semiconductor industry applications, the cold plasma technology does not require a vacuum chamber. The plasma discharge is conducted in the open air.
- The mean electron energy (or temperature) of a cold plasma is considerably higher than that of the bulk-gas molecules. Energy is primarily added to the electrons rather than the ions and background gas molecules, and the electrons can attain energies of approximately 10−1 eV or higher, while background gas remains at ambient temperature. A significant energy savings can be realized since electrons are preferentially excited and larger ions are left in a lower energy state in a cold plasma.
- A plasma may also be formed when a modulated electric field is applied to a pair of electrodes and exposed to the gas. The plasma formation can cause oxygen molecules of the air passing near the electrodes to break down into component molecules, including reactive oxygen species (“ROS”). Organic substrates, such as bacteria, viruses, microbes and mold spores can be exposed to ROS, and then destroyed or rendered harmless rapidly. The same reaction can convert much or all of the ROS back into oxygen.
- Cold plasmas can provide rapid decontamination of clothing, equipment or gear, and sterilization of medical equipment or food. However, while present methods of decontamination and sterilization may require long periods of time, even hours or days and generate damaging heat in the process; a cold plasma of the present disclosure can often sanitize an area or object very briefly, in seconds or minutes.
- It would be advantageous in a number a fields to provide a cold plasma that can decontaminate or sterile large areas rapidly.
- This disclosure relates to a decontamination Device having, at least, a gas source, where the gas is typically an inert gas, a gas manifold, at least one resistor network, which may be formed of various types of resistors, and a power source. The Device forms a plasma that may be employed to decontaminate large areas rapidly and efficiently in a variety applications.
-
FIG. 1 is a cross-sectional view of the general formation of the bulk distributed resistor. - The disclosed atmospheric discharge cold plasma device (the “Device”) is a large-area mechanism to provide decontamination, sterilization and general “clean-up” with, inter alia, nuclear fallout or waste, biologicals, chemicals, and industrial waste. The Device may be employed in any setting, including in urban outdoor areas, in medical facilities, military facilities, airplane hangers, storage facilities, inside tanks and other holding facilities, and the like. The Device may be operated remotely, preset for operation, or manually operated. It may also be disposable or reusable. The Device provides great advantages over the cold plasma prior art, which is generally directed to medical uses, because very large areas may be decontaminated or sterilized rapidly, and no prior preparation of the area is required in any way. Electrosurgical uses of plasma are disclosed in, inter alia, U.S. Application 2004/0116918, which is incorporated herein in its entirety.
- The Device's plasma beam is emitted via the applicator portion of the Device and can have multiple modes of action to achieve the desired effect. These modes include ion bombardment, electron bombardment, thermal effects, ultra-violet emissions, and the local generation of ozone. Via any of these modes, and combinations thereof, the flowing inert carrier gas can help carry away debris, and expose a clean, fresh surface. The ratio of electrical energy input to carrier gas flow rate can be adjusted over a wide range, to allow the overall effect to be varied over a wide range.
- The device has a scalable approach to producing a large area plasma applicator, which can range from approximately one millimeter diameter pin-point beam to a much larger area beam array, which may be approximately a square meter area or more. A large plasma beam area can be employed as a plasma scrub brush for use in a variety of situations for decontamination and/or sterilization. Devices can be built in a manner that allows flexibility and can adjust to contoured surfaces. Such flexibility may be employed in an even wider number of circumstances including holding tanks, reactors, and the like.
- One of the primary benefits of the Device, and atmospheric discharge cold plasma technology, is the combined impact of multiple modes of action that provide an antimicrobial action against a wide spectrum of organisms and spores, including bacteria, viruses, microbes, fungi, and the like. This same effect would allow for decontamination of a wide spectrum of biological agents typically deployed in biological weapons of mass destruction, and yet cause little or no collateral damage to the substrate during decontamination. The Device can be formed to permit safe and relatively rapid decontamination of large affected areas as compared to more typical or traditional clean-up methods. In addition, the Device does not use hazardous chemicals or generate hazardous waste streams, unlike previously known devices and clean-up methods.
- The Device may also be employed against chemicals using the same modes of plasma action by breaking down chemical bonds of chemical weapons agents, by reducing chemicals to simple compounds such as water, carbon dioxide, and the like. The Device as a plasma scrub bush would be particularly effective to decontaminate porous substrates and surfaces which are highly problematic in such situations. The Device can decontaminate the porous surfaces of these substrates because the individual plasma beams can travel to the substrate surface despite uneven surface levels. Again, the Device has little or no deleterious effect(s) on the substrate itself.
- The Device may also be used to remove, isolate or destroy radioisotope compounds, particularly those associated with weapons. Currently, no technology exists in the prior art to reduce the specific activity of radioisotopes, which can be deployed in a weapon, or so called “dirty bomb”. The goal of removing and isolating radioisotopes from the affected area can be accomplished by applying the cold plasma technology in a practical large area applicator such as the plasma scrub brush. The Device frees the isotopes from the contaminated surface for subsequent removal. For example, a radioactive compound can be broken down into its constituent components, including water. The isotope can then be removed from the substrate with the Device and disposed of readily with the other components.
- Plasma “preprocessing” is employed in various industries to remove contaminants from surfaces. At higher powers, the plasma preprocessing can also roughen surfaces on a micro scale and in the case of polymers, create dangling bonds. These processes are used to enhance subsequent surface procedures such as coatings, adhesion and the like but typically require the use of a vacuum chamber in the prior art to apply a plasma at sub-atmospheric pressures. This is particularly problematic with large or oddly shaped/non symmetrical objects or surfaces. The Device can be employed to preprocess or treat objects of any arbitrary size or shape in a safe environment. Preprocessing with the Device can also permit rapid assessment of effectiveness of any preprocessing procedure, and allow subsequent processes to proceed as may be necessary without breaking a vacuum seal, if a vacuum used. For example, preprocessing of surfaces for hip or knee implant replacements can improve bone adhesion(s). Preprocessing can also, for example, promote adhesion of non-stick materials to other substrates or assist adhesion of markings to surfaces where the necessary markings would otherwise wipe off.
- The Device may be formed in any convenient physical size depending on an intended use. Medical use Devices may be small hand-held tools or larger wall-mounted tools on swing arms or tracks to be positioned as necessary during a medical procedure. Medical Devices may be formed as single-use articles or multiple use with re-sterilization. Larger Devices may be formed in the sizes of household or industrial vacuums, or in any convenient size that may fulfill a particular or general use need. The Device may use any convenient power source, which may generally be determined by the intended use at the time of manufacture. For example, a Device intended for reuse or multiple uses that might be employed, for example, in a hospital setting may run via an electrical cord. Alternatively, a Device that is manufactured for a one time use may be run on a battery, or, perhaps, a solar charge battery for larger areas.
- The
Device 100 can include a gas storage tank, or holding location, and typically the gas would be a noble or inert gas, such as helium or argon. The gas storage tank can be operatively connected to aconduit 102 to provide a source of gas to be fed into the Device. Theconduit 102, in turn, leads to theelectrodes 104. Theelectrodes 104, when activated, at least partially ionize the gas to create the plasma stream or streams 106. The number ofplasma streams 106 will be dependent on the size of theDevice 100 itself, and the size of the Device applicator which may be formed as large as approximately a square meter or more. -
Power input 108 into theDevice 100 can run through apower distribution electrode 110 into a bulk distributedresistor 112, as described below, or individual ballast resistors depending on the size of the applicator. Aplasma beam 106 can be formed by passing the gas over a sharp conductive point, generally of an electrical flow wire, which is held at a relatively high voltage, generally greater than 1 KV, and at a relatively high frequency, generally in the range of approximately 10 KHz to approximately 10 GHz. Alternatively, a sintered metal component may be employed to provide a sharp conductor necessary to create the strong electric field gradient which helps pull electrons off the inert gas molecules and ionize them. The metal particle edges of a sintered metal component can act as sharp conductive points. Ballast resistors may be employed to prevent plasma beams from simultaneously functioning or firing, as depicted inFIG. 1 . The plasma beam may exhibit negative resistance and can prevent additional beams from functioning or firing. The associated resistance values can range from approximately 1 KΩ to approximately 10 MΩ. - Individual resistors, at least one resistor or a plurality of resistors, may be used in cases where the number of resistors necessary or required to function with the area of a particular applicator would not become unwieldy. However, individual resistors can be problematic where large numbers of resistors may be involved as in large area applicators. Rather than employ several hundreds or thousands of resistors for use with one applicator, a combined bulk distributed resistor can be used as a resistor network.
- The bulk distributed resistor can be formed of a slow cure epoxy that can be blended with at least one conductive component to produce a desired level of equivalent resistance. Alternatively, the bulk distributed resistor may be formed of other materials, such as, for example, room-temperature vulcanizing (“RTV”) rubber, silicones, polymers, and other materials and combinations that can combine with conductive components and that can be hardened or harden sufficiently for use. The conductive component can be formed of carbon nanotubes, carbon fibers, graphite powers, conductive metal particles, conductive metal oxides, conductive polymers, or a combination thereof. The conductive component may form a percentage of the resistor material in the range of approximately 0.1% or less to approximately 80% or some what higher. In another embodiment, the amount of conductive materials formed in the resistor may be in the range of approximately 25% to approximately 60%. In yet another embodiment, the amount of conductive materials formed in the resistor may be in the range of approximately 35% to approximately 45%. The epoxy is poured into an appropriate mold, depending, inter alia, on the desired size, shape and flexibility for a particular form of the Device. The epoxy may then be subjected to vacuum degassing to remove most, if not all, of any air bubbles that may have formed during the molding process.
- The bulk distributed resistor can be formed in a pin grid array. A pin grid array can be inserted into the epoxy to an approximate depth of not more than half the depth of the mold and rigidly held in the desired position until the epoxy has cured. Once the epoxy has cured, the hardened epoxy is removed from the mold and the pin array, leaving individual channels for emitting a plasma beam through the applicator. The equivalent resistance of the bulk distributed resistor can have values of approximately 1 KΩ to approximately 10 MΩ between any pin and a common distribution electrode.
- A
common distribution electrode 110 can be attached to the epoxy surface near thepower input source 108. Theelectrode 110 may be formed of conductive paints, an additional epoxy layer of higher conductivity, a metal plate or some combination thereof. A plurality of channels may be formed through the bulk resistor to allow electrical flow, or other type of power, to contact the gas as the gas flows through agas manifold 103 having aninput 102 that is connected, directly or indirectly, to the gas storage tank. The electrical flow can ionize the gas as the power passes into thegas manifold 103 and forms aplasma stream 106 at the point of theelectrical flow wire 104. Theplasma stream 106 may then flow through an emitter oroutput channel 114 that is operatively formed on thegas manifold 103 approximately opposite thebulk resistor 112. A myriad number ofplasma beam emitters 114 may be formed. Theemitters 114 can transect the Device applicator to allow the plasma beams 106 to contact a surface outside theDevice 100. Decontamination of a surface in contact with the Device'splasma beam 106 then occurs rapidly, with seconds or minutes. Decontamination time frames may vary based on a number of factors, including the type of surface, the type of contamination, additional biological and/or chemical compounds present, and temperature. - Alternatively, an intermediate electronegative gas conduit may optionally be disposed in a coaxial relationship relative to the gas conduit. A second gas conduit can be used to supply an electronegative gas, or air such as oxygen and nitrogen to maintain the plasma stream. Optionally, an outer aspiration conduit may also be coupled to a negative pressure source, such as a vacuum, that can be disposed in surrounding coaxial relationship, and also recessed, relative to the electronegative gas conduit. An aspiration conduit can optionally be used to remove fluid and solid debris from the decontamination area, if desired.
- Generally, oxygen and nitrogen in the atmosphere surrounding a plasma beam can tend to confine the plasma discharge to an elongated narrow beam. However, if plasma is applied to an enclosed or internal cavity, the gas flow from the plasma stream displaces any air remaining within the cavity. In order to maintain the profile of the plasma stream within a confined space, the intermediate electronegative gas conduit can be employed. This intermediate electronegative gas conduit extends beyond the inner gas conduit in order to maintain a laminar coaxial flow. Gas and air flow rates are generally equal. However, air flow rates in excess of the gas flow rate can be used to enhance flow-assisted removal of smoke and debris generated during use of the Device, if desired. Excessive flow rates of either the gas or air can induce turbulence in the plasma stream and distort the discharge jet shape.
- Cross-boundary diffusion from the plasma stream into the surrounding air and air diffusion into the plasma stream can limit the effective length of the plasma stream. Inert gas can be substituted in place of additional gas flow in the intermediate electronegative gas conduit, which can significantly extend the plasma stream, if desired for a specific environment. A reduced concentration gradient of the gas can occur from an ionized jet diffusing into non-ionized gas and vice versa. This reduced concentration gradient can result in an overall plasma stream that can be approximately two and two and one-half times as long as plasma streams without a coaxial gas flow.
- It will be appreciated that the disclosed Device addresses the pressing problem of decontaminating an area without further risk to life or exposure. A contaminated area can be secured and sterilized or decontaminated without direct human contact in a large number of settings that would prove unsafe or even dangerous for humans in short term of prolonged contact with the contaminants. The Device is also ideal for decontamination of interior surfaces and areas, such as holding tanks, because the Device can be formed using a flexible applicator to adapt to specific environments and uses, and avoid human exposure to high contamination levels enclosed within a tank.
- In addition, the disclosed cold plasma Device has many uses in different fields and applications, such as, inter alia, control of air flow over a variety of airfoil surfaces, including missiles, airplane wings, airplane rudders and the like. Use of the Devise for plasma actuation may provide rapid control of the air flow for enhanced control of the direction and maneuverability. Such uses include those disclosed in U.S. Pat. Nos. 7,070,144, and 7,275,013; and U.S. Patent Applications 2006/0005545, and 2007/0089795, each of which is incorporated herein in its entirety. For example, US Patent Application 2007/0089795 discloses a fluid actuator, or a plurality of actuators, having two conductors, or a plurality of conductors, on a dielectric. The application of voltage to a conductor may form a plasma flow which can be modified and controlled in a desired direction.
- Also disclosed are microwave absorbing characteristics of discharge plasmas which may form a “plasma shield” at higher intensities. Such a plasma shield would prove an effective defense against beamed-microwave directed energy weapons. Moreover, where a plasma absorbed such directed energy, the plasma's degree of ionization will increase, to become more effective and self-reinforcing. Such disclosures include U.S. Pat. Nos. 4,897,285 and 6,492,951, which are incorporated herein in their entirety.
- The Device, and its bulk resistor system, may be employed with any of the incorporated disclosures, above. The Device may provide highly efficient applications of plasma having greater plasma output over a greater surface area, according to the desired use.
- It should be understood that the foregoing description is only illustrative of the invention. Various alternatives and modifications can be devised by those skilled in the art without departing from the invention. Accordingly, the present invention is intended to embrace all such alternatives, modifications and variances which fall within the scope of the appended claims.
Claims (17)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14/455,910 US20140341786A1 (en) | 2008-02-02 | 2014-08-10 | Cold plasma setrilization device |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/012,446 US8377388B2 (en) | 2008-02-02 | 2008-02-02 | Cold plasma decontamination device |
US13/768,180 US8802022B2 (en) | 2008-02-02 | 2013-02-15 | Cold plasma sterilization device |
US14/455,910 US20140341786A1 (en) | 2008-02-02 | 2014-08-10 | Cold plasma setrilization device |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/768,180 Continuation US8802022B2 (en) | 2008-02-02 | 2013-02-15 | Cold plasma sterilization device |
Publications (1)
Publication Number | Publication Date |
---|---|
US20140341786A1 true US20140341786A1 (en) | 2014-11-20 |
Family
ID=43062423
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/012,446 Active 2029-06-04 US8377388B2 (en) | 2008-02-02 | 2008-02-02 | Cold plasma decontamination device |
US13/768,180 Active US8802022B2 (en) | 2008-02-02 | 2013-02-15 | Cold plasma sterilization device |
US14/455,910 Abandoned US20140341786A1 (en) | 2008-02-02 | 2014-08-10 | Cold plasma setrilization device |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/012,446 Active 2029-06-04 US8377388B2 (en) | 2008-02-02 | 2008-02-02 | Cold plasma decontamination device |
US13/768,180 Active US8802022B2 (en) | 2008-02-02 | 2013-02-15 | Cold plasma sterilization device |
Country Status (1)
Country | Link |
---|---|
US (3) | US8377388B2 (en) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108601606A (en) * | 2015-12-02 | 2018-09-28 | 博为医疗公司 | Mix cold plasma beam stream and air |
US10281043B2 (en) | 2015-07-10 | 2019-05-07 | Lockheed Martin Corporation | Carbon nanotube based thermal gasket for space vehicles |
US10692704B2 (en) | 2016-11-10 | 2020-06-23 | Gojo Industries Inc. | Methods and systems for generating plasma activated liquid |
US10716611B2 (en) | 2015-05-15 | 2020-07-21 | ClearIt, LLC | Systems and methods for tattoo removal using cold plasma |
US10765850B2 (en) | 2016-05-12 | 2020-09-08 | Gojo Industries, Inc. | Methods and systems for trans-tissue substance delivery using plasmaporation |
US10918433B2 (en) | 2016-09-27 | 2021-02-16 | Apyx Medical Corporation | Devices, systems and methods for enhancing physiological effectiveness of medical cold plasma discharges |
US11490947B2 (en) | 2015-05-15 | 2022-11-08 | Clear Intradermal Technologies, Inc. | Tattoo removal using a liquid-gas mixture with plasma gas bubbles |
US11911090B2 (en) | 2018-12-19 | 2024-02-27 | Clear Intradermal Technologies, Inc. | Systems and methods for tattoo removal using an applied electric field |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7633231B2 (en) | 2007-04-23 | 2009-12-15 | Cold Plasma Medical Technologies, Inc. | Harmonic cold plasma device and associated methods |
US8115135B2 (en) * | 2008-02-14 | 2012-02-14 | Adventix Technologies Inc. | Plasma assisted oxygen decontaminant generator and sprayer |
US9649143B2 (en) * | 2009-09-23 | 2017-05-16 | Bovie Medical Corporation | Electrosurgical system to generate a pulsed plasma stream and method thereof |
US8795265B2 (en) | 2010-01-28 | 2014-08-05 | Bovie Medical Corporation | Electrosurgical apparatus to generate a dual plasma stream and method thereof |
US8742932B2 (en) * | 2010-06-07 | 2014-06-03 | Carlos Maxwell Casares | Hand wash and sanitation device |
US9199026B2 (en) | 2011-01-07 | 2015-12-01 | Somerset Group Enterprises, Inc. | Modular extracorporeal systems and methods for treating blood-borne diseases |
US9387269B2 (en) | 2011-01-28 | 2016-07-12 | Bovie Medical Corporation | Cold plasma jet hand sanitizer |
US9375525B2 (en) * | 2012-01-09 | 2016-06-28 | Somerset Group Enterprises, Inc. | Modular extracorporeal systems and methods for treating blood-borne diseases |
US9295280B2 (en) * | 2012-12-11 | 2016-03-29 | Plasmology4, Inc. | Method and apparatus for cold plasma food contact surface sanitation |
CN106535811A (en) | 2014-01-24 | 2017-03-22 | 伊卢森特医药公司 | Systems and methods comprising localization agents |
US9987097B2 (en) | 2015-10-02 | 2018-06-05 | Elucent Medical, Inc. | Signal tag detection components, devices, and systems |
US9730764B2 (en) | 2015-10-02 | 2017-08-15 | Elucent Medical, Inc. | Signal tag detection components, devices, and systems |
EP3355782B1 (en) | 2015-10-02 | 2024-01-24 | Elucent Medical, Inc. | Signal tag detection systems |
US10154799B2 (en) | 2016-08-12 | 2018-12-18 | Elucent Medical, Inc. | Surgical device guidance and monitoring devices, systems, and methods |
RU2749804C1 (en) * | 2017-08-04 | 2021-06-17 | Ю.С. Пейтент Инновейшнс Ллк | Diffusion applicator for cold atmospheric plasma system |
WO2019130223A1 (en) * | 2017-12-30 | 2019-07-04 | 3M Innovative Properties Company | Plasma sterilization and drying system and methods |
US10278779B1 (en) | 2018-06-05 | 2019-05-07 | Elucent Medical, Inc. | Exciter assemblies |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8267884B1 (en) * | 2005-10-07 | 2012-09-18 | Surfx Technologies Llc | Wound treatment apparatus and method |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3820237C1 (en) | 1988-06-14 | 1989-09-14 | Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften Ev, 3400 Goettingen, De | |
DE19806516A1 (en) * | 1998-02-17 | 1999-08-19 | Ruediger Haaga Gmbh | Sterilization assembly for containers using low pressure plasma |
US6027616A (en) * | 1998-05-01 | 2000-02-22 | Mse Technology Applications, Inc. | Extraction of contaminants from a gas |
AUPP635298A0 (en) | 1998-10-06 | 1998-10-29 | Australian National University, The | Plasma antenna |
US6764658B2 (en) * | 2002-01-08 | 2004-07-20 | Wisconsin Alumni Research Foundation | Plasma generator |
JP2005528737A (en) * | 2002-03-28 | 2005-09-22 | アピト コープ.エス.アー. | Atmospheric plasma surface treatment method and apparatus for executing the same |
US7316682B2 (en) | 2002-12-17 | 2008-01-08 | Aaron Medical Industries, Inc. | Electrosurgical device to generate a plasma stream |
US6685143B1 (en) | 2003-01-03 | 2004-02-03 | Orbital Research Inc. | Aircraft and missile forebody flow control device and method of controlling flow |
US7334394B2 (en) | 2003-09-02 | 2008-02-26 | The Ohio State University | Localized arc filament plasma actuators for noise mitigation and mixing enhancement |
US7275013B1 (en) | 2004-09-20 | 2007-09-25 | University Of Notre Dame Duloc | Plasma anemometer and method for using same |
EP1705965A1 (en) * | 2005-03-21 | 2006-09-27 | Universiteit Gent | Method and system for plasma treatment under high pressure |
US7615931B2 (en) * | 2005-05-02 | 2009-11-10 | International Technology Center | Pulsed dielectric barrier discharge |
US7703479B2 (en) | 2005-10-17 | 2010-04-27 | The University Of Kentucky Research Foundation | Plasma actuator |
-
2008
- 2008-02-02 US US12/012,446 patent/US8377388B2/en active Active
-
2013
- 2013-02-15 US US13/768,180 patent/US8802022B2/en active Active
-
2014
- 2014-08-10 US US14/455,910 patent/US20140341786A1/en not_active Abandoned
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8267884B1 (en) * | 2005-10-07 | 2012-09-18 | Surfx Technologies Llc | Wound treatment apparatus and method |
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11439453B2 (en) | 2015-05-15 | 2022-09-13 | Clear Intradermal Technologies, Inc. | Systems and methods for tattoo removal using cold plasma |
US12064160B2 (en) | 2015-05-15 | 2024-08-20 | Clear Intradermal Technologies, Inc. | Tattoo removal using a liquid-gas mixture with plasma gas bubbles |
US10716611B2 (en) | 2015-05-15 | 2020-07-21 | ClearIt, LLC | Systems and methods for tattoo removal using cold plasma |
US11490947B2 (en) | 2015-05-15 | 2022-11-08 | Clear Intradermal Technologies, Inc. | Tattoo removal using a liquid-gas mixture with plasma gas bubbles |
US10281043B2 (en) | 2015-07-10 | 2019-05-07 | Lockheed Martin Corporation | Carbon nanotube based thermal gasket for space vehicles |
US11129665B2 (en) | 2015-12-02 | 2021-09-28 | Apyx Medical Corporation | Mixing cold plasma beam jets with atmopshere |
CN108601606A (en) * | 2015-12-02 | 2018-09-28 | 博为医疗公司 | Mix cold plasma beam stream and air |
US10765850B2 (en) | 2016-05-12 | 2020-09-08 | Gojo Industries, Inc. | Methods and systems for trans-tissue substance delivery using plasmaporation |
US11724078B2 (en) | 2016-05-12 | 2023-08-15 | Gojo Industries, Inc. | Methods and systems for trans-tissue substance delivery using plasmaporation |
US10918433B2 (en) | 2016-09-27 | 2021-02-16 | Apyx Medical Corporation | Devices, systems and methods for enhancing physiological effectiveness of medical cold plasma discharges |
US11696792B2 (en) | 2016-09-27 | 2023-07-11 | Apyx Medical Corporation | Devices, systems and methods for enhancing physiological effectiveness of medical cold plasma discharges |
US11735399B2 (en) | 2016-11-10 | 2023-08-22 | Gojo Industries, Inc. | Methods and systems for generating plasma activated liquid |
US10692704B2 (en) | 2016-11-10 | 2020-06-23 | Gojo Industries Inc. | Methods and systems for generating plasma activated liquid |
US11911090B2 (en) | 2018-12-19 | 2024-02-27 | Clear Intradermal Technologies, Inc. | Systems and methods for tattoo removal using an applied electric field |
Also Published As
Publication number | Publication date |
---|---|
US8802022B2 (en) | 2014-08-12 |
US20140030162A1 (en) | 2014-01-30 |
US20100284867A1 (en) | 2010-11-11 |
US8377388B2 (en) | 2013-02-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8802022B2 (en) | Cold plasma sterilization device | |
Machala et al. | Plasma agents in bio-decontamination by dc discharges in atmospheric air | |
US9601317B2 (en) | Cold plasma sanitizing device | |
US6113851A (en) | Apparatus and process for dry sterilization of medical and dental devices and materials | |
US20090206062A1 (en) | Portable Plasma Sterilizer | |
WO2010107722A1 (en) | Tubular floating electrode dielectric barrier discharge for applications in sterilization and tissue bonding | |
KR101409390B1 (en) | Apoptosis method of abnormal cell useing atmospheric pressure plasma for bio-medical applications | |
JP3974442B2 (en) | Sterilization apparatus and sterilization method | |
CN104225638A (en) | Plasma atomized sterilization device with temperature of lower than 80 DEG C | |
CN104013985A (en) | Portable micro-plasma sterilizer | |
JP2020516431A (en) | Device for human medical or veterinary treatment and method for producing reactive gas usable in plasma therapy | |
Morent et al. | Inactivation of bacteria by non-thermal plasmas | |
KR101600991B1 (en) | Sterilization and detoxification apparatus of packing cover using plasma and reactive gas | |
CN104940966A (en) | Endoscope sterilization device combining jet flow discharge plasma with surface discharge plasma | |
CN110996488A (en) | Medical plasma jet device | |
WO2008026366A1 (en) | Surface treatment method and apparatus | |
Rongsangchaicharean et al. | Effect of dielectric barrier discharge plasma on rice (Oryza sativa L.) seed hydration and hygroscopicity | |
San-Xi et al. | The interaction of an atmospheric pressure plasma jet using argon or argon plus hydrogen peroxide vapour addition with bacillus subtilis | |
CN111494668B (en) | Sterilization method | |
JP4075869B2 (en) | Purification device | |
CN213373889U (en) | Electromagnetic mask sterilizer | |
CN111420109B (en) | Electromagnetic pulse synergistic plasma efficient air purification and disinfection equipment | |
JP2023529593A (en) | Sterilizer for generating plasma and hydroxyl radicals | |
Feng et al. | Ar plasma jet generation and its application for water and surface sterilization | |
US20210000146A1 (en) | System and method for food sterilization |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: BOVIE MEDICAL CORPORATION, FLORIDA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:KONESKY, GREGORY;REEL/FRAME:033502/0681 Effective date: 20140810 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |
|
AS | Assignment |
Owner name: MIDCAP FUNDING IV TRUST, MARYLAND Free format text: SECURITY INTEREST;ASSIGNOR:APYX MEDICAL CORPORATION;REEL/FRAME:062913/0001 Effective date: 20230217 |
|
AS | Assignment |
Owner name: APYX MEDICAL CORPORATION, FLORIDA Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:MIDCAP FUNDING IV TRUST;REEL/FRAME:065612/0105 Effective date: 20231108 |